C

Captor Capital Corp
CNSX:CPTR

Watchlist Manager
Captor Capital Corp
CNSX:CPTR
Watchlist
Price: 0.275 CAD 14.58%
Market Cap: 954.3k CAD

Relative Value

There is not enough data to reliably calculate the relative value of CPTR.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CPTR Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
93
Median 3Y
0.2
Median 5Y
7.1
Industry
2.6
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
-15.6
Industry
21.6
vs History
vs Industry
50
Median 3Y
-1.4
Median 5Y
-40.3
Industry
16.5
vs History
vs Industry
36
Median 3Y
-1.1
Median 5Y
-25.7
Industry
22.5
vs History
96
vs Industry
82
Median 3Y
0.3
Median 5Y
6.6
Industry
2.3
vs History
0
vs Industry
92
Median 3Y
-0.1
Median 5Y
7.2
Industry
2.9
vs History
vs Industry
87
Median 3Y
-0.5
Median 5Y
17.6
Industry
5.5
vs History
vs Industry
48
Median 3Y
-4.9
Median 5Y
-30.1
Industry
13
vs History
vs Industry
35
Median 3Y
-4.7
Median 5Y
-23.6
Industry
16.6
vs History
12
vs Industry
48
Median 3Y
1.5
Median 5Y
-36.2
Industry
15.8
vs History
12
vs Industry
37
Median 3Y
1.5
Median 5Y
-34
Industry
19.1
vs History
vs Industry
83
Median 3Y
-0.4
Median 5Y
4.9
Industry
1.9

Multiples Across Competitors

CPTR Competitors Multiples
Captor Capital Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Captor Capital Corp
CNSX:CPTR
958.9k CAD -5.8 -0 -5 -5
US
Eli Lilly and Co
NYSE:LLY
988.4B USD 16.7 54.1 36 38.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
514B USD 5.6 20.4 16.7 21.7
CH
Roche Holding AG
SIX:ROG
255.9B CHF 4.2 27.1 11.6 13.5
UK
AstraZeneca PLC
LSE:AZN
209.3B GBP 4.8 29.8 108.2 158.3
CH
Novartis AG
SIX:NOVN
207B CHF 4.6 18.1 11.5 14.8
US
Merck & Co Inc
NYSE:MRK
242B USD 3.8 12.7 9.1 10.8
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.4 9.4 10.9
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
146B USD 2.3 14.8 7.5 10.3
P/S Multiple
Revenue Growth P/S to Growth
CA
C
Captor Capital Corp
CNSX:CPTR
Average P/S: 71.5
Negative Multiple: -5.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
16.7
26%
0.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
578.3
9%
64.3
US
Johnson & Johnson
NYSE:JNJ
5.6
6%
0.9
CH
Roche Holding AG
SIX:ROG
4.2
3%
1.4
UK
AstraZeneca PLC
LSE:AZN
4.8
8%
0.6
CH
Novartis AG
SIX:NOVN
4.6
5%
0.9
US
Merck & Co Inc
NYSE:MRK
3.8
4%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
4.4
6%
0.7
IE
E
Endo International PLC
LSE:0Y5F
90.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
2.3
-2%
N/A
P/E Multiple
Earnings Growth PEG
CA
C
Captor Capital Corp
CNSX:CPTR
Average P/E: 23.8
Negative Multiple: -0
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.1
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.4
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.1
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.8
38%
0.8
CH
Novartis AG
SIX:NOVN
18.1
17%
1.1
US
Merck & Co Inc
NYSE:MRK
12.7
15%
0.8
DK
Novo Nordisk A/S
CSE:NOVO B
13.4
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.8
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
C
Captor Capital Corp
CNSX:CPTR
Average EV/EBITDA: 438.7
Negative Multiple: -5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.7
9%
1.9
CH
Roche Holding AG
SIX:ROG
11.6
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.2
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.1
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.4
2%
4.7
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
1%
7.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
C
Captor Capital Corp
CNSX:CPTR
Average EV/EBIT: 1 881.2
Negative Multiple: -5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.6
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.7
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.5
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.3
23%
6.9
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.8
8%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
8%
1.3